scholarly journals The role and importance of the European Union and the WHO (World Health Organization) in ensuring social safety during the COVID-19 pandemic

2021 ◽  
Vol 9 (6) ◽  
pp. 34-39
Author(s):  
Magdalena Molendowska

Purpose of the study: The object of the analysis is to evaluate the effectiveness of the measures taken by international organizations in the fight against the COVID-19 pandemic and thus to assess the effectiveness in ensuring public security. Two very important organizations were chosen for the analysis – the European Union, whose competences resulting from treaty provisions do not directly concern health, and in contrast – the World Health Organization (WHO), which was established to promote, ensure, and protect health. Methodology: The paper was prepared based on critical analysis of literature and the uncontrolled observation method. Main findings: The methods, forms of action and measures adopted to combat the pandemic, both by the EU and the WHO, cannot be described as fully effective. This was due to many reasons, different for both organizations, including lack of experience, adequate preparation, response time, information flow, access to vaccines, etc. Nevertheless, both organizations played a very important role. The EU has played and continues to play an integrating role, providing a sense of solidarity in the fight against the pandemic. The WHO, in turn, acts as an authority in the medical field, its guidelines and recommendations are credible to most of the international community. Application of the study: The presented article refers to the issue of security in a crisis situation, which is the COVID-19 pandemic. It implies reflections in such scientific fields as, among others security, healty and psychology. In addition, the study may be relevant to the discussion on strengthening the competences of the EU and WHO. Original/Novelty of the study: The subject matter addressed is very timely, in fact we are all caught up in the problem identified. The fight against the pandemic is still on and the current assessment is probably only a fraction of the research that can be fully presented once the pandemic is over. Therefore, the article may serve as an inspiration to continue deliberations about this topic. Perhaps only the invention of an effective drug, rather than a vaccine for COVID-19, can be declared a battle won.

2004 ◽  
Vol 8 (24) ◽  
Author(s):  

The World Health Organization (WHO) Regional Office for Europe has recently published a booklet entitled 10 Health Questions about the 10, which gives an overview of trends in population health and healthcare systems in the 10 new member states of the European Union


2009 ◽  
Vol 37 (10) ◽  
pp. 827-834 ◽  
Author(s):  
Hugo Sax ◽  
Benedetta Allegranzi ◽  
Marie-Noëlle Chraïti ◽  
John Boyce ◽  
Elaine Larson ◽  
...  

2020 ◽  
Vol 27 (3) ◽  
pp. 232-241
Author(s):  
Claudia Seitz

Abstract The current pandemic outbreak of corona virus SARS-CoV-2 shows the need for comprehensive European cooperation in drug development and the importance of genetic material and sequence data in research concerning this unknown disease. As corona virus SARS-CoV-2 is spreading across Europe and worldwide, national authorities and the European Union (EU) institutions do their utmost to address the pandemic and accelerate innovation to protect global health. In order to be prepared and to be able to respond immediately to serious epidemic and pandemic diseases, the EU has already adopted the Decision No (EU) 1082/2013 on serious cross-border threats to health. The World Health Organization (WHO) has established a global system to collect genetic material and information to protect a global influenza pandemic outbreak. The article describes the current legal landscape under EU and international law.


2019 ◽  
Vol 60 (3) ◽  
pp. 406-415 ◽  
Author(s):  
Raúl López-López ◽  
Mariano Sánchez

Abstract Background and Objectives The paradigm of active aging has been slowly gaining ground in Europe as the ideal framework for public policy and for responding to the population’s aging. Taking the work by Rune Ervik as its point of departure, this article updates his conclusions on conceptualizations and policies of active aging by performing a study of the institutional discourses in the matter produced by the World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), and the European Union (EU). Methods A corpus of 15 WHO, OECD, and EU documents published in the period 2002–2015 and tackling active aging were analyzed qualitatively through a combination of content and thematic analysis, based on a scheme integrated by deductive and inductive iterative manual and computerized codification. Results The institutional discourses on active aging analyzed have not changed dramatically in the period considered. However, a divergent path has emerged regarding the accent placed on participation and contribution in the construction of the paradigm: the more socially productive and health-oriented WHO discourse is slowly separating from the more economically productive and labor-oriented discourses of the EU and OECD. Discussion and Implications The institutional paradigm on active aging is evolving into a reductive treatment of a phenomenon that is multidimensional. International institutions and researchers should pay closer attention and forge a path toward an honest and critical examination of the real conditions and expectations of older people concerning the discursive and practical proposals of active aging, in all its different forms.


Author(s):  
Pol Rovira ◽  
Jürgen Rehm

Abstract Background Research has identified alcohol to be an important risk factor for several types of cancers. This study estimates the number of incident cancers attributable to alcohol consumption in the European Union (EU) in 2017, with a special focus on those caused by light to moderate drinking levels. Methods The attributable-fraction methodology is used to estimate the number of new cancer cases in the year 2017 in the EU caused by alcohol use, and further examines those due to light to moderate drinking levels, defined here as alcohol consumption of <20 g of pure alcohol per day. Results Light to moderate drinking levels of alcohol caused almost 23 000 new cancer cases in the EU in 2017, and accounted for 13.3% of all alcohol-attributable cancers, and 2.3% of all cases of the seven alcohol-related cancer types. Almost half of these (∼11 000 cases) were female breast cancers. Also, more than a third of the cancer cases due to light to moderate drinking resulted from a light drinking level of <1 standard drink per day (total: 37%; women: 40%; men: 32%). Conclusions Alcohol use, including light to moderate drinking, continues to cause considerable cancer burden, and efforts should be made to reduce this burden. In addition to the alcohol control policies suggested by the World Health Organization, public information campaigns and the placement of warning labels on alcohol containers advising of the cancer risk associated with alcohol use should be initiated to increase knowledge about the alcohol-cancer link.


2003 ◽  
Vol 7 (1) ◽  
Author(s):  

The European Programme for Intervention Epidemiology Training (EPIET) started in 1995. The programme is funded by the European Commission and by various European Union (EU) member states as well as Norway and the World Health Organization (WHO). Subject to agreement for another round of funding, the ninth cohort of fellows will start in October 2003. The programme invites applications for 10 fellowships for this 24 month training programme in communicable disease field epidemiology.


Sign in / Sign up

Export Citation Format

Share Document